Long-read genome sequencing resolves complex structural variants in exome-negative developmental and epileptic encephalopathy
Abstract
Background and Objectives: Developmental and Epileptic Encephalopathies (DEEs) encompass a clinically and molecularly heterogeneous group of mainly genetic disorders. Despite standard genetic testing, approximately two-thirds of patients remain undiagnosed. Pathogenic noncoding and structural variants (SVs), particularly complex rearrangements that are difficult to detect or resolve using short-read sequencing, may contribute to this diagnostic gap. To evaluate the diagnostic contribution of long-read genome sequencing (lrGS), we recruited a cohort of 124 families with sporadic DEE who remained unsolved by prior ES. Methods: Trio lrGS (Oxford Nanopore or PacBio HiFi) was performed, complemented zby short-read genome sequencing (srGS) and mRNA sequencing (blood or fibroblast) of index cases, where available. Comprehensive variant analysis included small nucleotide variants (SNVs), indels, SVs, and short tandem repeats. To identify the diagnostic yield of each method, we compared lrGS, srGS and ES re-analysis, and evaluated the additional value of RNA sequencing. Results: We established a diagnosis in 21 of 124 families (16.9%). Fourteen variants were retrospectively detectable in prior ES., Two cases with non-coding variants in SCN1A and RNU2-2 were detectable by both srGS and lrGS. Five SVs also required genome sequencing (5.6% of the total cohort), three of which could be detected, but not confidently resolved by srGS due to breakpoint complexity, repeat-mediated rearrangements, and large copy-neutral events: LrGS enabled accurate characterization of Alu-mediated CDKL5 and STXBP1 deletions and a MEF2C deletion with large inversion. A copy-neutral SCN1A inversion was well characterizable by both srGS and lrGS. One balanced translocation t(X;17) disrupting CDKL5 was resolved by lrGS (srGS unavailable). RNA sequencing confirmed pathogenicity of two SVs including t(X;17), the MEF2C deletion with inversion, and two CNVs. In addition, ZNF569 and ZNF570 emerged as candidate epilepsy genes from our cohort. Discussion: In ES-negative DEE, the incremental diagnostic yield of genome sequencing was modest, while lrGS provided particular value for the structural resolution of complex rearrangements, especially those involving repetitive sequences. The finding that two-thirds of diagnoses were retrospectively detectable in prior ES highlights the substantial value of systematic reanalysis. Further gains from genome sequencing may increasingly depend on improved interpretation of non-coding variation and integration of long-read-specific information. Our findings indicate that complex SVs represent the class for which lrGS currently yields the most distinctive diagnostic information.
Related
- Neonatal-onset developmental and epileptic encephalopathy: High genetic yield and long-term outcomes in a multicenter southern European cohort.
- Novel Genetic Variants of the CHD2 Gene in cis Position in a Patient with Epileptic Encephalopathy: A Case Report and In Silico Analysis of the Impact of the Variants on the Protein
- Caregiver perceptions of telemedicine in developmental and epileptic encephalopathies: a nationwide Spanish survey
- Genetic developmental and epileptic encephalopathies in adulthood: Gaps in evidence and care.
- Beyond seizures: the hidden burden of developmental epileptic encephalopathies
BibTeX
@misc{park2026longread,
title = {{Long-read genome sequencing resolves complex structural variants in exome-negative developmental and epileptic encephalopathy}},
author = {J. Park and Z. Eddafir and J. Kegele and D. Mei and N. Smal and C. Vossler-Wolf and K. Ellwanger and C. Millevert and M. Swinnen and R. Lauerer-Braun and H. Loeffler and T. Ott and G. Demidov and M. Alber and F. Bisulli and S. Byrne and L. Canafoglia and E. Carapancea and B. Castellotti and G. Cavalleri and N. Chatron and M. R. Cilio and J. Coleman and E. De Vriendt and W. De Coster and M. De Wachter and A. Esteve-Codina and F. Fineschi and E. Freri and J. Gagneur and H. Ghani and M. Gheisari and A. Jansen and J. Kenny and P. Krieg and L. Licchetta and O. Maier and E. Matzker and R. Minardi and H. Muhle and B. A. Neubauer and S. Olivieri and S. Ossowski and E. Parrini and Pendziw},
howpublished = {medRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.26.26365902},
url = {https://www.medrxiv.org/content/10.64898/2026.10.26.26365902v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Long-read genome sequencing resolves complex structural variants in exome-negative developmental and epileptic encephalopathy
AU - J. Park
AU - Z. Eddafir
AU - J. Kegele
AU - D. Mei
AU - N. Smal
AU - C. Vossler-Wolf
AU - K. Ellwanger
AU - C. Millevert
AU - M. Swinnen
AU - R. Lauerer-Braun
AU - H. Loeffler
AU - T. Ott
AU - G. Demidov
AU - M. Alber
AU - F. Bisulli
AU - S. Byrne
AU - L. Canafoglia
AU - E. Carapancea
AU - B. Castellotti
AU - G. Cavalleri
AU - N. Chatron
AU - M. R. Cilio
AU - J. Coleman
AU - E. De Vriendt
AU - W. De Coster
AU - M. De Wachter
AU - A. Esteve-Codina
AU - F. Fineschi
AU - E. Freri
AU - J. Gagneur
AU - H. Ghani
AU - M. Gheisari
AU - A. Jansen
AU - J. Kenny
AU - P. Krieg
AU - L. Licchetta
AU - O. Maier
AU - E. Matzker
AU - R. Minardi
AU - H. Muhle
AU - B. A. Neubauer
AU - S. Olivieri
AU - S. Ossowski
AU - E. Parrini
AU - Pendziw
PY - 2026
DA - 2026/10/26
PB - medRxiv
DO - 10.64898/2026.10.26.26365902
UR - https://www.medrxiv.org/content/10.64898/2026.10.26.26365902v1
AB - Background and Objectives: Developmental and Epileptic Encephalopathies (DEEs) encompass a clinically and molecularly heterogeneous group of mainly genetic disorders. Despite standard genetic testing, approximately two-thirds of patients remain undiagnosed. Pathogenic noncoding and structural variants (SVs), particularly complex rearrangements that are difficult to detect or resolve using short-read sequencing, may contribute to this diagnostic gap. To evaluate the diagnostic contribution of long-read genome sequencing (lrGS), we recruited a cohort of 124 families with sporadic DEE who remained unsolved by prior ES. Methods: Trio lrGS (Oxford Nanopore or PacBio HiFi) was performed, complemented zby short-read genome sequencing (srGS) and mRNA sequencing (blood or fibroblast) of index cases, where available. Comprehensive variant analysis included small nucleotide variants (SNVs), indels, SVs, and short tandem repeats. To identify the diagnostic yield of each method, we compared lrGS, srGS and ES re-analysis, and evaluated the additional value of RNA sequencing. Results: We established a diagnosis in 21 of 124 families (16.9%). Fourteen variants were retrospectively detectable in prior ES., Two cases with non-coding variants in SCN1A and RNU2-2 were detectable by both srGS and lrGS. Five SVs also required genome sequencing (5.6% of the total cohort), three of which could be detected, but not confidently resolved by srGS due to breakpoint complexity, repeat-mediated rearrangements, and large copy-neutral events: LrGS enabled accurate characterization of Alu-mediated CDKL5 and STXBP1 deletions and a MEF2C deletion with large inversion. A copy-neutral SCN1A inversion was well characterizable by both srGS and lrGS. One balanced translocation t(X;17) disrupting CDKL5 was resolved by lrGS (srGS unavailable). RNA sequencing confirmed pathogenicity of two SVs including t(X;17), the MEF2C deletion with inversion, and two CNVs. In addition, ZNF569 and ZNF570 emerged as candidate epilepsy genes from our cohort. Discussion: In ES-negative DEE, the incremental diagnostic yield of genome sequencing was modest, while lrGS provided particular value for the structural resolution of complex rearrangements, especially those involving repetitive sequences. The finding that two-thirds of diagnoses were retrospectively detectable in prior ES highlights the substantial value of systematic reanalysis. Further gains from genome sequencing may increasingly depend on improved interpretation of non-coding variation and integration of long-read-specific information. Our findings indicate that complex SVs represent the class for which lrGS currently yields the most distinctive diagnostic information.
ER -